Abstract:Neurodegenerative diseases are closely related to inflammatory and autoimmune events, suggesting that the dysregulation of the immune system is a key pathological factor. Both multiple sclerosis (MS) and Alzheimer's disease (AD) are characterized by infiltrating immune cells, activated microglia, astrocyte proliferation, and neuronal damage. Moreover, MS and AD share a common pro-inflammatory signature, characterized by peripheral leukocyte activation and transmigration to the central nervous system (CNS). MS and AD are both characterized by the accumulation of activated neutrophils in the blood, leading to progressive impairment of the blood–brain barrier. Having migrated to the CNS during the early phases of MS and AD, neutrophils promote local inflammation that contributes to pathogenesis and clinical progression. The role of circulating T cells in MS is well-established, whereas the contribution of adaptive immunity to AD pathogenesis and progression is a more recent discovery. Even so, blocking the transmigration of T cells to the CNS can benefit both MS and AD patients, suggesting that common adaptive immunity mechanisms play a detrimental role in each disease. There is also growing evidence that regulatory T cells are beneficial during the initial stages of MS and AD, supporting the link between the modulatory immune compartments and these neurodegenerative disorders. The number of resting regulatory T cells declines in both diseases, indicating a common pathogenic mechanism involving the dysregulation of these cells, although their precise role in the control of neuroinflammation remains unclear. The modulation of leukocyte functions can benefit MS patients, so more insight into the role of peripheral immune cells may reveal new targets for pharmacological intervention in other neuroinflammatory and neurodegenerative diseases, including AD.

The contribution of the peripheral immune system to neurodegeneration

The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases

Immune mechanisms and shared immune targets in neurodegenerative diseases

Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease

Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer's disease

Peripheral and Central Nervous System Immune Response Crosstalk in Amyotrophic Lateral Sclerosis

CNS and CNS Diseases in Relation to Their Immune System

Frontiers of Neurodegenerative Disease Treatment: Targeting Immune Cells in Brain Border Regions

Microglia in Neurodegenerative Diseases

Immunological aspects of central neurodegeneration

Neuroimmunity in amyotrophic lateral sclerosis: focus on microglia

Neuroinflammation in Alzheimer's disease: insights from peripheral immune cells

Boosting peripheral immunity to fight neurodegeneration in the brain

Common Peripheral Immunity Mechanisms in Multiple Sclerosis and Alzheimer's Disease

The Neuro-Inflammatory Microenvironment: an Important Regulator of Stem Cell Survival in Alzheimer’s Disease

Peripheral and central immune system crosstalk in Alzheimer disease — a research prospectus

Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets

Emergence of the brain-border immune niches and their contribution to the development of neurodegenerative diseases

Immune Regulatory Functions of Macrophages and Microglia in Central Nervous System Diseases

Frontiers of neurodegeneration diseases treatment: Targeting immune cells in brain border regions

Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications